Medication info
Phenacet Tablet (Tramadol Hydrochloride, Acetaminophen)

Phenacet Tablet (Tramadol Hydrochloride, Acetaminophen)

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›18.75mg / 1 tabletAcetaminophen›162.5mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
Light yellow oblong film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200805387 · Notified 2008.05.13 · Insurance code 646002780

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 4 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and the dose should not exceed 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Elderly patients Use the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance below 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: An initial dose of 4 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and the dose should not exceed 16 tablets per day.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute and chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 4 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and the dose should not exceed 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Elderly patients Use the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance below 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: An initial dose of 4 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and the dose should not exceed 16 tablets per day.

Precautions

This medication may strain the liver, so individuals who regularly consume more than three drinks per day should consult a doctor or pharmacist before use. The acetaminophen included in this medication can rarely cause serious skin reactions; therefore, if a skin rash or hypersensitivity reaction occurs, discontinue use immediately and consult healthcare personnel. The main component, tramadol, may increase the risk of seizures if taken in doses higher than recommended, and the risk of seizures can be further increased if taken with certain antidepressants or other narcotic analgesics. Patients with impaired respiratory function or those with acute and severe bronchial asthma should use this medication with extra caution and should be in an environment where resuscitation equipment is available. Combining this medication with alcohol or central nervous system depressants may lead to severe sedation or respiratory depression, so this should be avoided. Patients with elevated intracranial pressure or head injury should be cautious when using this medication, as symptoms may worsen. This drug may cause psychological and physical dependence, so careful observation is needed for dependency when used for an extended period. Patients with compromised liver function must consult a doctor before taking this medication, and overdosing on acetaminophen should be avoided. Patients with certain genetic metabolic characteristics may produce excessive active metabolites, increasing the risk of serious side effects such as respiratory depression, so caution is advised. This medication should not be given to children under 12 years of age or teenagers under 18 who have undergone tonsillectomy or adenoidectomy, and it is advisable to avoid administering this drug to those aged 12 to 18 with risk factors. Patients with sleep apnea or hypoxemia should continuously monitor symptoms during use of this medication and consider dosage adjustments or discontinuation if necessary. Hyponatremia may occur while using this medication; therefore, particularly elderly patients or those at risk for hyponatremia should monitor symptoms. Individuals with a history of allergy to this medication’s components, central nervous system drug addiction, severe respiratory depression, head injury, or those currently taking MAO inhibitors should not receive this medication. This medication may cause drowsiness or dizziness; caution should be taken when driving or operating machinery. In case of overdose, serious respiratory depression or liver damage may occur, and immediate contact with a medical institution and appropriate treatment should be sought. This medication should be stored in a safe place out of the reach of children, and care should be taken to prevent drug misuse or accidents.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, fatal respiratory inhibition, hyponatremia, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, indigestion, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, decreased libido, sleep disorders, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, somnolence, sensory loss, tremors, paresthesia, attention deficit, syncope, memory impairment, psychomotor hyperactivity, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, cold sweat, urinary disorders, erectile dysfunction, weakness, chest pain, emotional abnormalities, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, hot flashes, weight loss, increased serum creatinine, anaphylactic reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, emotional instability, delirium, suicidal ideation, hypertonia, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disorders, prolonged prothrombin time, fixed rash, weakness, fever, edema, rigidity, syncope, congestive heart failure, confusion, exacerbation of migraine, involuntary contractions of muscles, exertional dyspnea, cough, bronchitis, urinary retention, frequent urination, abnormal kidney function values, oliguria, increased sweating, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, increased white blood cells, decreased white blood cells, decreased platelets, arrhythmia, exacerbation of hypertension, aortic stenosis, hemorrhage, elevated cholesterol, tinnitus, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of biliary tract cancer, foreign body sensation in the eye, progression of liver cancer, liver dysfunction, nausea, constipation, vomiting, vertigo, confusion, delirium, multiple organ failure, intentional overdose, chest discomfort, drowsiness, insomnia, loss of appetite, anxiety, depression, nervousness, emotional instability, hallucinations, depersonalization

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent air ingress, maintaining a storage temperature between 1 degree and 30 degrees Celsius room temperature. This will help maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

Light yellow oblong film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.